Hancock Whitney’s Fulgent Genetics FLGT Stock Holding History

Hancock Whitney’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,231	Closed	-$206K	–	720
2021 Q2	$206K	Buy	+2,231	New	+$178K	0.01%	759

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Hancock Whitney's FLGT Position: Q3 2021 in Review

Hancock Whitney sold out of Fulgent Genetics (FLGT) in Q3 2021, closing a stake of 2,231 shares — an estimated $206K sold.

Hancock Whitney first reported a position in FLGT in Q2 2021 and held it in 1 quarter. The position peaked at $206K in Q2 2021. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

Hancock Whitney reported no remaining Fulgent Genetics position as of Q3 2021 after selling out during the quarter.
Hancock Whitney sold 2,231 Fulgent Genetics shares in Q3 2021, an estimated $206K.
Hancock Whitney first reported a position in Fulgent Genetics in Q2 2021 and held it in 1 quarter.
Hancock Whitney's Fulgent Genetics position peaked at $206K in Q2 2021.
268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.